Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$772M |
| 2 |
Eli Lilly
LLY
|
+$337M |
| 3 |
lululemon athletica
LULU
|
+$301M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$297M |
| 5 |
ResMed
RMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$576M |
| 2 |
AT&T
T
|
+$476M |
| 3 |
PNC Financial Services
PNC
|
+$393M |
| 4 |
Fortive
FTV
|
+$389M |
| 5 |
Accenture
ACN
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.83% |
| 2 | Technology | 2.79% |
| 3 | Financials | 2.29% |
| 4 | Consumer Discretionary | 1.93% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BCYC
4076
Bicycle Therapeutics
BCYC
$273M
| $4.08M | ﹤0.01% |
+243,334
| New | +$5.13M |
|
4077
PUT
Acuity Brands
AYI
$10.7B
| $4.08M | ﹤0.01% |
26,500
+22,300
| +531% | +$3.78M |
|
4078
General Dynamics
GD
$107B
| $4.08M | ﹤0.01% |
18,449
-333,785
| -95% | -$76.8M |
|
|
AVLR
4079
PUT
DELISTED
Avalara, Inc.
AVLR
| $4.08M | ﹤0.01% |
57,800
-800
| -1% | -$65.8K |
|
4080
PUT
Lattice Semiconductor
LSCC
$18.5B
| $4.08M | ﹤0.01% |
84,100
+45,400
| +117% | +$2.26M |
|
4081
Travel + Leisure Co
TNL
$4.63B
| $4.08M | ﹤0.01% |
104,980
-184,208
| -64% | -$9.09M |
|
4082
First Trust Developed Markets ex-US AlphaDEX Fund
FDT
$1.34B
| $4.07M | ﹤0.01% |
85,030
+39,025
| +85% | +$2.09M |
|
4083
Nordic American Tanker
NAT
$1.42B
| $4.07M | ﹤0.01% |
1,911,543
+1,689,250
| +760% | +$4.04M |
|
4084
Eagle Bancorp
EGBN
$878M
| $4.06M | ﹤0.01% |
85,740
+76,038
| +784% | +$3.82M |
|
4085
LCI Industries
LCII
$2.58B
| $4.06M | ﹤0.01% |
36,301
-29,289
| -45% | -$3.2M |
|
4086
PUT
Tower Semiconductor
TSEM
$30B
| $4.06M | ﹤0.01% |
87,900
-39,600
| -31% | -$1.89M |
|
|
CCXI
4087
CALL
DELISTED
ChemoCentryx, Inc.
CCXI
| $4.06M | ﹤0.01% |
163,800
-11,900
| -7% | -$262K |
|
4088
Invesco S&P 500 High Dividend Low Volatility ETF
SPHD
$3.44B
| $4.06M | ﹤0.01% |
91,902
+74,845
| +439% | +$3.49M |
|
|
MPT
4089
Medical Properties Trust
MPT
$2.5B
| $4.05M | ﹤0.01% |
265,538
+229,934
| +646% | +$4.14M |
|
4090
VanEck Oil Services ETF
OIH
$2B
| $4.05M | ﹤0.01% |
17,433
-34,987
| -67% | -$9.59M |
|
4091
CALL
Brunswick
BC
$5.36B
| $4.05M | ﹤0.01% |
62,000
-31,000
| -33% | -$2.28M |
|
4092
PUT
Veru
VERU
$46.5M
| $4.05M | ﹤0.01% |
35,840
+31,430
| +713% | +$3.65M |
|
|
AUY
4093
PUT
DELISTED
Yamana Gold, Inc.
AUY
| $4.04M | ﹤0.01% |
869,800
-106,200
| -11% | -$576K |
|
4094
Essential Properties Realty Trust
EPRT
$6.72B
| $4.04M | ﹤0.01% |
188,011
-22,505
| -11% | -$523K |
|
|
MAG
4095
DELISTED
MAG Silver
MAG
| $4.04M | ﹤0.01% |
331,940
+167,887
| +102% | +$2.46M |
|
4096
PUT
Mattel
MAT
$4.29B
| $4.04M | ﹤0.01% |
180,800
-145,100
| -45% | -$3.43M |
|
4097
PUT
EPR Properties
EPR
$4.69B
| $4.03M | ﹤0.01% |
85,900
-18,300
| -18% | -$927K |
|
4098
CALL
Madrigal Pharmaceuticals
MDGL
$11.7B
| $4.03M | ﹤0.01% |
56,300
+36,000
| +177% | +$2.65M |
|
|
BDN
4099
Brandywine Realty Trust
BDN
$532M
| $4.03M | ﹤0.01% |
417,702
+81,626
| +24% | +$921K |
|
4100
Vanguard Russell 2000 ETF
VTWO
$17.6B
| $4.03M | ﹤0.01% |
+58,880
| New | +$4.38M |
|
Similar funds
Ken Griffin's Q2 2022 Portfolio in Review
As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.
By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.
- Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
- Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
- Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
- Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
- Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
- Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
- Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.
Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.